Ticker Scorecard - CRVS Basics Company: Corvus Pharmaceuticals, Inc. Common Stock IPO Date: March 21, 2016 Sector: Healthcare Industry: Biotech Market Cap: $270.52M Activated in VL: True Average Daily Range Avg Daily Range: $0.19 | 3.70% Avg Daily Range (30 D): $0.15 | 3.26% Avg Daily Range (90 D): $0.22 | 3.59% Institutional Daily Volume Avg Daily Volume: .51M Avg Daily Volume (30 D): .52M Avg Daily Volume (90 D): .78M Trade Size Avg Trade Size (Sh.): 220 Avg Trade Size (Sh.) (30 D): 99 Avg Trade Size (Sh.) (90 D): 118 Institutional Trades Total Inst.Trades: 118 Avg Inst. Trade: $1.43M Avg Inst. Trade (30 D): $.57M Avg Inst. Trade (90 D): $1.09M Avg Inst. Trade Volume: .23M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.71M Avg Closing Trade (30 D): $.65M Avg Closing Trade (90 D): $1.1M Avg Closing Volume: 246.91K     News Dec 18, 2024 @ 11:22 AM US Stocks To Open Higher As Rate Cut Expectations ... Source: Rishabh Mishra Nov 14, 2024 @ 3:01 PM Corvus Pharmaceuticals Announces New Preclinical D... Source: N/A Nov 9, 2024 @ 6:40 PM Corvus Pharmaceuticals Announces New Data Highligh... Source: N/A Nov 6, 2024 @ 9:59 AM T-Cell Lymphoma Pipeline Insight Analysis Report 2... Source: Researchandmarkets.Com May 6, 2024 @ 8:01 PM Corvus Pharmaceuticals Provides Business Update an... Source: Corvus Pharmaceuticals, Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.99 $-.6 $-.07 Diluted EPS $-.99 $-.6 $-.07 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -56.83M $ -40.22M $ -4.26M Operating Income / Loss $ -25.09M $ -7.26M $ -5.94M Cost of Revenue $ $ $ Net Cash Flow $ -15.43M $ -10.16M $ 2.22M PE Ratio